Showing results (511-520 of 534) with videos related to
Sort By:
Pageof 54
Blood Advances|November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantationMadhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2010
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trialPaul G Richardson, Robert J Soiffer, Joseph H Antin, et al.Blood Advances|June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantationRoni Tamari, Michael Scordo, Binni M Kunvarjee, et al.Blood|October 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P Margossian, Nancy A Kernan, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|September 30, 2022
Mortality Risk in Pediatric Sepsis Based on C-reactive Protein and Ferritin LevelsChristopher M Horvat, Anthony Fabio, Daniel S Nagin, et al.Stroke|October 21, 2024
2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke AssociationCheryl Bushnell, Walter N Kernan, Anjail Z Sharrief, et al.The New England Journal of Medicine|February 18, 2016
Pioglitazone after Ischemic Stroke or Transient Ischemic AttackWalter N Kernan, Catherine M Viscoli, Karen L Furie, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Ex Vivo CD34<sup>+</sup>-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment ResponsePere Barba, Patrick Hilden, Sean M Devlin, et al.Journal of Clinical Immunology|January 1, 2022
Prevalence of Pathogenic and Potentially Pathogenic Inborn Error of Immunity Associated Variants in Children with Severe SepsisKate F Kernan, Lina Ghaloul-Gonzalez, Jerry Vockley, et al.Pageof 54